Identification of a Missense Mutation and Several Polymorphisms in the Proenkephalin a Gene of Schizophrenic Patients

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 5, 1996, Pages 459-467

  Mikesell, M J ^a   Sobell, J L ^a   Sommer, S S ^a   McMurray, C T ^a  

^a MAYO CLINIC   (United States)

Author keywords

Candidate gene; Genetics; Opioid; Schizophrenia

Indexed keywords

PROENKEPHALIN;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; SCHIZOPHRENIA;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; CODON; CONSERVED SEQUENCE; ENKEPHALINS; EXONS; HUMANS; POINT MUTATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; SCHIZOPHRENIA; VARIATION (GENETICS);

EID: 0029784435     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960920)67:5<459::AID-AJMG4>3.0.CO;2-F     Document Type: Article

References (38)

1. American Psychiatrie Association (1987): "Diagnostic and Statistical Manual of Mental Disorders," Third Edition, Revised. Washington, DC: American Psychiatric Association.
2. 2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. J Neurochem 58:1104-1109.
3. Carpenter WT Jr, Buchanan RW (1994): Schizophrenia (review). N Engl J Med 330:681-690.
4. 1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum. Neurochem Int 25:355-366.
5. Creese I, Burt DR, Snyder SH (1976): Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
6. Docherty K, Steiner DF (1982): Post-translational proteolysis in polypeptide hormone biosynthesis. Annu Rev Physiol 44:625-638.
7. Ellington A, Cherry JM (1995): "Current Protocols in Molecular Biology." New York: John Wiley, and Sons, Vol. 3, pp A.1.8-A.1.9.
8. Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D, Blum K, Noble EP, Kranzler HR, O'Malley S, et al. (1994): No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. JAMA 271:204-208.
9. Glavac D, Dean M (1993): Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat 2:404-414.
10. Gustafson S, Proper JA, Bowie EJW, Sommer SS (1987): Parameters affecting the yield of DNA from human blood. Analyt Biochem 145:294-299.
11. Kakidani H, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S (1982): Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature 298:245-249.
12. Kendler KS (1983): Overview. A current perspective on twin studies of schizophrenia. Am J Psychiatry 140:1413-1425.
13. Kendler KS, Diehl SR (1993): The genetics of schizophrenia: A current, genetic-epidemiologic perspective. Schizophrenia Bull 19: 261-285.
14. Kendler KS, Gruenberg AM, Tsuang MT (1985): Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. Arch Gen Psychiatry 42:770-779.
15. Kilpatrick DL, Taniguchi T, Jones BN, Stern AS, Shively JE, Hullihan J, Kimura S, Stein S, Udenfriend S (1981): A highly potent 3200-dalton adrenal opioid peptide that contains both a [Met]- and [Leu]enkephalin sequence. Proc Natl Acad Sei USA 78:3265-3268.
16. Lindberg I, White L (1986): Distribution of immunoreactive peptide B in the rat brain. Biochem Biophys Res Commun 139:1024-1032.
17. Liu Q, Sommer SS (1994): Parameters affecting the sensitivities of dideoxy fingerprinting and SSCP. PCR Methods Applic 4:97-108.
18. Lowing PA, Mirsky AF, Pereira R (1983): The inheritance of schizophrenia spectrum disorders: A reanalysis of the Danish adoption study data. Am J Psychiatry 140:1167-1171.
19. McGuffin P, Owen MJ, Farmer AE (1995): Genetic basis of schizophrenia. Lancet 346:678-682.
20. Nakanishi S, Inoue A, Kita T, Nakamura M, Chang ACY, Cohen SN, Numa S (1979): Nucleotide sequence of cloned cDNA for bovine corticotropin-B-lipotropin precursor. Nature 278:423-427.
21. Nanko S, Fukuda R, Hattori M, Sasaki T, Dai XY, Gill M, Kuwata S, Shibata Y, Kazamatsuri H (1994): No evidence of linkage or allelic association of schizophrenia with DNA markers at pericentric region of chromosome 9. Biol Psychiatry 36:589-594.
22. Nemeroff CB, Bissette G (1988): Neuropeptides, dopamine, and schizophrenia. Ann NY Acad Sci 537:273-291.
23. Noda M, Teranishi Y, Takahashi H, Toyosato M, Notake M, Nakanishi S, Numa S (1982): Isolation and structural organization of the human preproenkephalin gene. Nature 297:431-434.
24. Onstad S, Skre I, Torgersen S, Kringlen E (1991): Twin concordance for DSM-III-R schizophrenia. Acta Psychiatr Scand 83:395-401.
25. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989): Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770.
26. Peroutka SJ, Snyder SH (1980): Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137:1518-1522.
27. 2 receptor in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 11:8-14.
28. Sarkar G, Yoon HS, Sommer SS (1992): Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations. Genomics 13:441-443.
29. Seeman P, Lee T, Chau-Wong M, Wong K (1976): Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719.
30. Sobell JL, Heston LL, Sommer SS (1993): Novel association approach for determining the genetic predisposition to schizophrenia: Casecontrol resource and testing of a candidate gene. Am J Med Genet 48:28-35.
31. 4 receptor variants in unrelated schizophrenic cases and controls. Am J Med Genet 48:90-93.
32. Stern AS, Jones BN, Shively JE, Stein S, Udenfriend S (1981): Two adrenal opioid polypeptides: Proposed intermediates in the processing of proenkephalin. Proc Natl Acad Sci USA 78:1962-1966.
33. 2 dopamine receptor gene region of chromosome 11q in 112 Irish multiplex families. Arch Gen Psychiatry 50:205-211.
34. Tang F, Costa E, Schwartz JP (1983): Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci USA 80: 3841-3844.
35. Van Nispen JW, Van Wimersma Greidanus TB (1990): Neuropeptides and behavioral adaptation: Structure-activity relationships. In De Wied D (ed): "Neuropeptides: Basics and Perspectives." Amsterdam: Elsevier, pp 213-254.
36. Watkinson A, Young J, Varro A, Dockray GJ (1989): The isolation and chemical characterization of phosphorylated enkephalin-containing peptides from bovine adrenal medulla. J Biol Chem 264:3061-3065.
37. Wiegant VM, Ronken E, Kovacs G, De Wied D (1992): Endorphins and schizophrenia. In Swaab DF, Hofman M, Mirmiran M, Ravid R, van Leeuwen FW (eds): "Progress in Brain Research." Amsterdam: Elsevier, pp 433-453.
38. 3 dopamine receptor gene. Am J Med Genet 48:83-86.